Xencor, Inc. (XNCR) Rockets on Licensing Deal With Novartis AG (NVS)

Shares of Monrovia, California, based Xencor, Inc. (XNCR) rose on Tuesday, against the backdrop of a strong day in stocks overall. Xencor's stock was up 32.06%, rising $4.02 per share, to close at $16.56, on volume of 3,102,591 shares. The company announced a licensing deal with Novartis AG (NVS) on two early stage blood cancer ... READ MORE Read the rest of Xencor, Inc. (XNCR) Rockets on Licensing Deal With Novartis AG (NVS) at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.